Please login to the form below

Not currently logged in
Email:
Password:

pricing

This page shows the latest pricing news and features for those working in and with pharma, biotech and healthcare.

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Merck & Co joins big pharma pricing pledge – but sceptics unconvinced

Merck &Co joins big pharma pricing pledge – but sceptics unconvinced. ... These elements are all coming together to produce a very different tone on pharma pricing, but just how far it will extend into policy and legislation is yet to be seen.

Latest news

More from news
Approximately 93 fully matching, plus 827 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 16 fully matching, plus 138 partially matching documents found.

Latest appointments

  • Weekly comms appointments Weekly comms appointments

    Pyati’s new domain will see him grow and expand the group’s scientific and medical communications practice and integrating it with the firm’s analytics, digital and value, pricing and

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

  • Mereo BioPharma appoints head of patient access and commercial planning Mereo BioPharma appoints head of patient access and commercial planning

    In this role, Hughes-Wilson was responsible for Sobi’s commercialisation approach and led pricing, reimbursement and access teams for the group’s rare disease product portfolio.

  • W2O bolsters its commercialisation offering W2O bolsters its commercialisation offering

    W2O bolsters its commercialisation offering. Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Glaze has 25 years’experience in the biopharmaceutical and life science sector with expertise in marketing, managed

  • Hanover Brussels appoints Aurélie Marchand as account director Hanover Brussels appoints Aurélie Marchand as account director

    Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”.

More from appointments
Approximately 2 fully matching, plus 27 partially matching documents found.

Latest from PMHub

  • Valid Insight

    With a team that includes some of the world’ s leading market access and pricing experts, our clients trust us to help them navigate through the most challenging environments. ... We focus on pricing, market access and value communication strategy

  • Remap Consulting

    Remap Consulting. Remap Consulting is a specialist pharmaceutical pricing and market access consultancy. ... Our mission is to help solve your pricing and market access challenges to ensure improved patient access to your products.

  • Organisational Memory

    Then, a whole swathe of people are needed to get the product onto the market in the first place: pricing and reimbursement experts, government affairs, public relations people, and patient relations

  • When data are not enough...

    support premium pricing. increase the impact of promotional efforts. achieve product loyalty.

  • Understanding Patient Willingness to Pay

    What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets? ... Any successful pricing strategy therefore needs to start with an understanding of target patients’ willingness to pay

More from PMHub
Approximately 6 fully matching, plus 52 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics